Statistical designs for traditional phase I dose-finding trials consider dose-limiting toxicity in the first cycle of treatment. In reality, patients often go through multiple cycles of treatment and ...
Relationship between overall survival and progression-free survival for recent NCCTG glioblastoma multiforme trials. Consolidation reduced dose whole brain radiotherapy (rdWBRT) following methotrexate ...
In July, when the FDA approved Eisai and Biogen’s Alzheimer’s drug Leqembi, we noted the historic nature of the news: it’s the first approved Alzheimer's treatment clinically shown to slow disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback